Zdrowie i gospodarka · 17/03/2017

FDA Seeks Public Comment on Proposed Pharmacogenomic Data Collection

The Food and Drug Administration (FDA) is seeking public comment on its proposed collection of pharmacogenomic data during the drug development process, as required by the Paperwork Reduction Act of 1995. The agency will allow 60 days for public input on the proposed data collection.